Skip to main content
. Author manuscript; available in PMC: 2014 Jul 9.
Published in final edited form as: Circulation. 2013 Jun 11;128(2):10.1161/CIRCULATIONAHA.112.001075. doi: 10.1161/CIRCULATIONAHA.112.001075

Figure 7.

Figure 7

Intracoronary administration of CSCs promotes myocardial regeneration. Regenerated EGFP-positive myocytes in the infarcted region in a CSC-treated heart are labeled with α-sarcomeric actin (red) (A) and EGFP (green) (B). Panel (C) shows the combination of EGFP and α-sarcomeric actin (yellow-green).